Opioids Market By Product And Application - Global Industry Analysis And Forecast To 2023

Published On : May 2018 Pages : 190 Category: Healthcare IT Report Code : HC06823

Industry Outlook and Trend Analysis

The Opioids Market has encountered tremendous growth in the recent years and is foreseen to grow tremendously over the forecast period. Opioids are naturally occurring opiates and semi-synthetic and synthetic medications that act on opioid receptors present in the brain and can cause dependency because of their euphoric impacts. Opioids are significantly arranged into normal and engineered opioids that are used to treat moderate to extreme pain caused because of different physical conditions. Expanding usage of opioids in non-cancer conditions, unregulated prescription by doctors, absence of administrative strategies to curtail the abusive consumption, expanding the predominance of terminal conditions and ideal reimbursement for palliative care in developed nations are major variables boosting the development of the worldwide opioids market.

Product Outlook and Trend Analysis

On the basis of product the opioid market is segmented into codeine, fentanyl, morphine, methadone and meperidine. The morphine and codeine fragments comprehensively represented around 62% of the general market in 2014.

Application Outlook and Trend Analysis

Based on application the opioids market is portioned into cough suppression, analgesia and diarrhoea suppression. The analgesia portion was esteemed at US$ 22,776.3 Mn in 2014 and is foreseen to achieve significant growth over the conjecture time frame.

Regional Outlook and Trend Analysis

Geographically, North America ruled the market with more than 65% share of the overall industry in 2014, trailed by Europe. Opioids market in Asia-Pacific is anticipated to extend at the most astounding CAGR over the forecast period.

Competitive Insights

The leading players in the market are Sun Pharmaceutical Industries Ltd, Janssen Pharmaceutica NV, Egalet, Mallinckrodt, Pfizer, Actavis, Purdue Pharma, Boehringer Ingelheim and Sanofi. These organizations are searching for greatest shares of the overall industry with the assistance of product launch in Abuse Deterrent Formulations (ADF). Additionally, leading players are concentrating on Asia Pacific area particularly in Australia inferable from adaptable regulation for opium development.

The Opioids Market is segmented as follows-

By Product:

  • Morphine
  • Codeine
  • Fentanyl
  • Meperidine
  • Methadone

By Application:

  • Analgesia
  • Cough Suppression
  • Diarrhea Suppression

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Columbia
    • South Africa
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of MEA

Some of the key questions answered by the report are:

  • What was the market size in 2014 and forecast from 2015 to 2023?
  • What will be the industry market growth from 2015 to 2023?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Opioids Market, By Product, Estimates and Forecast, 2014-2023 ($Million)

·         Morphine

·         Codeine

·         Fentanyl

·         Meperidine

·         Methadone

·         Opioids Market, By Application, Estimates and Forecast, 2014-2023 ($Million)

·         Analgesia

·         Cough Suppression

·         Diarrhea Suppression

·         Opioids Market, By Region, Estimates and Forecast, 2014-2023 ($Million)

·         North America

§  North America Opioids Market, By Country

o    U.S. Opioids Market

o    Canada Opioids Market

o    Mexico Opioids Market

·         Europe

§  Europe Opioids Market, By Country

o    Germany Opioids Market

o    UK Opioids Market

o    France Opioids Market

o    Russia Opioids Market

o    Italy Opioids Market

o    Rest of Europe Opioids Market

·         Asia-Pacific

§  Asia-Pacific Opioids Market, By Country

o    China Opioids Market

o    Japan Opioids Market

o    South Korea Opioids Market

o    India Opioids Market

o    Southeast Asia Opioids Market

o    Rest of Asia-Pacific Opioids Market

·         South America

§  South America Opioids Market

o    Brazil Opioids Market

o    Argentina Opioids Market

o    Columbia Opioids Market

o    South Africa Opioids Market

o    Rest of South America Opioids Market

·         Middle East and Africa

§  Middle East and Africa Opioids Market

o    Saudi Arabia Opioids Market

o    UAE Opioids Market

o    Egypt Opioids Market

o    Nigeria Opioids Market

o    South Africa Opioids Market

o    Rest of MEA Opioids Market

Table of Contents

1.       Introduction

1.1.       Report Description

1.2.       Research Methodology

1.2.1.  Secondary Research

1.2.2.  Primary Research

2.       Executive Summary

2.1.       Key Highlights

3.       Market Overview

3.1.       Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.       Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

3.2.3.1.    Emerging Markets to Offer Lucrative Growth Opportunities

4.       Market Analysis by Regions

4.1.       North America (United States, Canada and Mexico)

4.1.1.  United States Market States and Outlook (2014-2023)

4.1.2.  Canada Market States and Outlook (2014-2023)

4.1.3.  Mexico Market States and Outlook (2014-2023)

4.2.       Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market States and Outlook (2014-2023)

4.2.2.  France Market States and Outlook (2014-2023)

4.2.3.  UK Market States and Outlook (2014-2023)

4.2.4.  Russia Market States and Outlook (2014-2023)

4.2.5.  Italy Market States and Outlook (2014-2023)

4.2.6.  Rest of Europe Market States and Outlook (2014-2023)

4.3.       Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market States and Outlook (2014-2023)

4.3.2.  Japan Market States and Outlook (2014-2023)

4.3.3.  Korea Market States and Outlook (2014-2023)

4.3.4.  India Market States and Outlook (2014-2023)

4.3.5.  Rest of Asia-Pacific Market States and Outlook (2014-2023)

4.4.       South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market States and Outlook (2014-2023)

4.4.2.  Argentina Market States and Outlook (2014-2023)

4.4.3.  Columbia Market States and Outlook (2014-2023)

4.4.4.  Rest of South America Market States and Outlook (2014-2023)

4.5.       Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market States and Outlook (2014-2023)

4.5.2.  UAE Market States and Outlook (2014-2023)

4.5.3.  Egypt Market States and Outlook (2014-2023)

4.5.4.  Nigeria Market States and Outlook (2014-2023)

4.5.5.  South Africa Market States and Outlook (2014-2023)

4.5.6.  Rest of MEA Market States and Outlook (2014-2023)

5.       Opioids Market, By Product

5.1.       Introduction

5.2.       Global Opioids Sales, Revenue and Market Share by Product (2014-2018)

5.2.1.  Global Opioids Sales and Sales Share by Product (2014-2018)

5.2.2.  Global Opioids Revenue and Revenue Share by Product (2014-2018)

5.3.       Morphine

5.3.1.  Global Morphine Sales and Growth Rate (2014-2018)

5.4.       Codeine

5.4.1.  Global Codeine Sales and Growth Rate (2014-2018)

5.5.       Fentanyl

5.5.1.  Global Fentanyl Sales and Growth Rate (2014-2018)

5.6.       Meperidine

5.6.1.  Global Meperidine Sales and Growth Rate (2014-2018)

5.7.       Methadone

5.7.1.  Global Methadone Sales and Growth Rate (2014-2018)

6.       Opioids Market, By Application

6.1.       Introduction

6.2.       Global Opioids Sales, Revenue and Market Share by Application (2014-2018)

6.2.1.  Global Opioids Sales and Sales Share by Application (2014-2018)

6.2.2.  Global Opioids Revenue and Revenue Share by Application (2014-2018)

6.3.       Analgesia

6.3.1.  Global Analgesia Sales and Growth Rate (2014-2018)

6.4.       Cough Suppression

6.4.1.  Global Cough Suppression Sales and Growth Rate (2014-2018)

6.5.       Diarrhea Suppression

6.5.1.  Global  Diarrhea Suppression Sales and Growth Rate (2014-2018)

7.       Opioids Market, By Region

7.1.       Introduction

7.2.       Global Opioids Sales, Revenue and Market Share by Regions

7.2.1.  Global Opioids Sales by Regions (2014-2018)

7.2.2.  Global Opioids Revenue by Regions (2014-2018)

7.3.       North America Opioids by Countries

7.3.1.  North America Opioids Sales and Growth Rate (2014-2018)

7.3.2.  North America Opioids Revenue and Growth Rate (2014-2018)

7.3.3.  North America Opioids Sales by Countries (2014-2018)

7.3.4.  North America Opioids Revenue (Million USD) by Countries (2014-2018)

7.3.5.  U.S.

7.3.5.1.    United States Opioids Sales and Growth Rate (2014-2018)

7.3.5.2.    United States Opioids Revenue (Millions USD) and Growth Rate (2014-2018)

7.3.6.  Canada

7.3.6.1.    Canada Opioids Sales and Growth Rate (2014-2018)

7.3.6.2.    Canada Opioids Sales (Millions USD) and Growth Rate (2014-2018)

7.3.7.  Mexico

7.3.7.1.    Mexico Opioids Sales and Growth Rate (2014-2018)

7.3.7.2.    Mexico Opioids Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.       Europe Opioids by Countries

7.4.1.  Europe Opioids Sales and Growth Rate (2014-2018)

7.4.2.  Europe Opioids Revenue and Growth Rate (2014-2018)

7.4.3.  Europe Opioids Sales by Countries (2014-2018)

7.4.4.  Europe Opioids Revenue (Million USD) by Countries (2014-2018)

7.4.5.  Germany

7.4.5.1.    Germany Opioids Sales and Growth Rate (2014-2018)

7.4.5.2.    Germany Opioids Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.6.  UK

7.4.6.1.    UK Opioids Sales and Growth Rate (2014-2018)

7.4.6.2.    UK Opioids Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.7.  France

7.4.7.1.    France Opioids Sales and Growth Rate (2014-2018)

7.4.7.2.    France Opioids Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.8.  Russia

7.4.8.1.    Russia Opioids Sales and Growth Rate (2014-2018)

7.4.8.2.    Russia Opioids Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.9.  Italy

7.4.9.1.    Italy Opioids Sales and Growth Rate (2014-2018)

7.4.9.2.    Italy Opioids Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.10.      Rest of Europe

7.4.10.1. Rest of Europe Opioids Sales and Growth Rate (2014-2018)

7.4.10.2. Rest of Europe Opioids Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.       Asia-Pacific

7.5.1.  Asia-Pacific Opioids Sales and Growth Rate (2014-2018)

7.5.2.  Asia-Pacific Opioids Revenue and Growth Rate (2014-2018)

7.5.3.  Asia-Pacific Opioids Sales by Countries (2014-2018)

7.5.4.  Asia-Pacific Opioids Revenue (Million USD) by Countries (2014-2018)

7.5.5.  China

7.5.5.1.    China Opioids Sales and Growth Rate (2014-2018)

7.5.5.2.    China Opioids Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.6.  Japan

7.5.6.1.    Japan Opioids Sales and Growth Rate (2014-2018)

7.5.6.2.    Japan Opioids Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.6.3.     

7.5.7.  Korea

7.5.7.1.    Korea Opioids Sales and Growth Rate (2014-2018)

7.5.7.2.    Korea Opioids Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.8.  India

7.5.8.1.    India Opioids Sales and Growth Rate (2014-2018)

7.5.8.2.    India Opioids Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.9.  Southeast Asia

7.5.9.1.    Southeast Asia Opioids Sales and Growth Rate (2014-2018)

7.5.9.2.    Southeast Asia Opioids Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.10.      Rest of Asia-Pacific

7.5.10.1. Rest of Asia-Pacific Opioids Sales and Growth Rate (2014-2018)

7.5.10.2. Rest of Asia-Pacific Opioids Revenue (Millions USD) and Growth Rate (2014-2018)

7.6.       South America

7.6.1.  South America Opioids Sales and Growth Rate (2014-2018)

7.6.2.  South America Opioids Revenue and Growth Rate (2014-2018)

7.6.3.  South America Opioids Sales by Countries (2014-2018)

7.6.4.  South America Opioids Revenue (Million USD) by Countries (2014-2018)

7.6.5.  Brazil

7.6.5.1.    Brazil Opioids Sales and Growth Rate (2014-2018)

7.6.5.2.    Brazil Opioids Revenue (Millions USD) and Growth Rate (2014-2018)

7.6.6.  Argentina

7.6.6.1.    Argentina Opioids Sales and Growth Rate (2014-2018)

7.6.6.2.    Argentina Opioids Revenue (Millions USD) and Growth Rate (2014-2018)

7.6.7.  Columbia

7.6.7.1.    Columbia Opioids Sales and Growth Rate (2014-2018)

7.6.7.2.    Columbia Opioids Revenue (Millions USD) and Growth Rate (2014-2018)

7.6.8.  Rest of South America

7.6.8.1.    Rest of South America Opioids Sales and Growth Rate (2014-2018)

7.6.8.2.    Rest of South America Opioids Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.       Middle East and Africa

7.7.1.  Middle East and Africa Opioids Sales and Growth Rate (2014-2018)

7.7.2.  Middle East and Africa Opioids Revenue and Growth Rate (2014-2018)

7.7.3.  Middle East and Africa Opioids Sales by Countries (2014-2018)

7.7.4.  Middle East and Africa Opioids Revenue (Million USD) by Countries (2014-2018)

7.7.5.  Saudi Arabia

7.7.5.1.    Saudi Arabia Opioids Sales and Growth Rate (2014-2018)

7.7.5.2.    Saudi Arabia Opioids Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.6.  United Arab Emirates

7.7.6.1.    United Arab Emirates Opioids Sales and Growth Rate (2014-2018)

7.7.6.2.    United Arab Emirates Opioids Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.7.  Egypt

7.7.7.1.    Egypt Opioids Sales and Growth Rate (2014-2018)

7.7.7.2.    Egypt Opioids Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.8.  Nigeria

7.7.8.1.    Nigeria Opioids Sales and Growth Rate (2014-2018)

7.7.8.2.    Nigeria Opioids Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.9.  South Africa

7.7.9.1.    South Africa Opioids Sales and Growth Rate (2014-2018)

7.7.9.2.    South Africa Opioids Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.10.      Rest of Middle East and Africa

7.7.10.1. Rest of Middle East and Africa Opioids Sales and Growth Rate (2014-2018)

7.7.10.2. Rest of Middle East and Africa Opioids Revenue (Millions USD) and Growth Rate (2014-2018)

8.       Company Profiles

8.1.         Pfizer Inc.

8.1.1.  Business Overview

8.1.2.  Product Portfolio

8.1.3.  Strategic Developments

8.1.4.  Sales, Revenue and Market Share

8.2.       Purdue Pharma

8.2.1.  Business Overview

8.2.2.  Product Portfolio

8.2.3.  Strategic Developments

8.2.4.  Sales, Revenue and Market Share

8.3.       Boehringer Ingelheim

8.3.1.  Business Overview

8.3.2.  Product Portfolio

8.3.3.  Strategic Developments

8.3.4.  Sales, Revenue and Market Share

8.4.       Janssen Pharmaceuticals, Inc.

8.4.1.  Business Overview

8.4.2.  Product Portfolio

8.4.3.  Strategic Developments

8.4.4.  Sales, Revenue and Market Share

8.5.       Actavis Plc.

8.5.1.  Business Overview

8.5.2.  Product Portfolio

8.5.3.  Strategic Developments

8.5.4.  Sales, Revenue and Market Share

8.6.       Sanofi

8.6.1.  Business Overview

8.6.2.  Product Portfolio

8.6.3.  Strategic Developments

8.6.4.  Sales, Revenue and Market Share

8.7.       Sun Pharmaceutical Industries Ltd

8.7.1.  Business Overview

8.7.2.  Product Portfolio

8.7.3.  Strategic Developments

8.7.4.  Sales, Revenue and Market Share

8.8.       Mallinckrodt Pharmaceuticals

8.8.1.  Business Overview

8.8.2.  Product Portfolio

8.8.3.  Strategic Developments

8.8.4.  Sales, Revenue and Market Share

8.9.       Endo Pharmaceuticals Inc.

8.9.1.  Business Overview

8.9.2.  Product Portfolio

8.9.3.  Strategic Developments

8.9.4.  Sales, Revenue and Market Share

8.10.    Egalet

8.10.1.      Business Overview

8.10.2.      Product Portfolio

8.10.3.      Strategic Developments

8.10.4.      Sales, Revenue and Market Share

9.       Global Opioids Market Competition, by Manufacturer

9.1.       Global Opioids Sales and Market Share by Manufacturer (2016-2017)

9.2.       Global Opioids Revenue and Market Share by Manufacturer (2016-2017)

9.3.       Global Opioids Price by Manufacturer (2016-2017)

9.4.       Top 5 Opioids Manufacturer Market Share

9.5.       Market Competition Trend

10.   Opioids Market Forecast (2018-2023)

10.1.    Global Opioids Sales, Revenue (Millions USD) and Growth Rate (2018-2023)

10.2.    Opioids Market Forecast by Regions (2018-2023)

10.2.1.      North America Opioids Market Forecast (2018-2023)

10.2.1.1. United States Opioids Market Forecast (2018-2023)

10.2.1.2. Canada Opioids Market Forecast (2018-2023)

10.2.1.3. Mexico Opioids Market Forecast (2018-2023)

10.2.2.      Europe Opioids Market Forecast (2018-2023)

10.2.2.1. Germany Opioids Market Forecast (2018-2023)

10.2.2.2. United Kingdom Opioids Market Forecast (2018-2023)

10.2.2.3. France Opioids Market Forecast (2018-2023)

10.2.2.4. Russia Opioids Market Forecast (2018-2023)

10.2.2.5. Italy Opioids Market Forecast (2018-2023)

10.2.2.6. Rest of the Europe Opioids Market Forecast (2018-2023)

10.2.3.      Asia-Pacific Opioids Market Forecast (2018-2023)

10.2.3.1. China Opioids Market Forecast (2018-2023)

10.2.3.2. Japan Opioids Market Forecast (2018-2023)

10.2.3.3. Korea Opioids Market Forecast (2018-2023)

10.2.3.4. India Opioids Market Forecast (2018-2023)

10.2.3.5. Southeast Asia Opioids Market Forecast (2018-2023)

10.2.3.6. Rest of Asia-Pacific Opioids Market Forecast (2018-2023)

10.2.4.      South America Opioids Market Forecast (2018-2023)

10.2.4.1. Brazil Opioids Market Forecast (2018-2023)

10.2.4.2. Argentina Opioids Market Forecast (2018-2023)

10.2.4.3. Columbia Opioids Market Forecast (2018-2023)

10.2.4.4. Rest of South America Opioids Market Forecast (2018-2023)

10.2.5.      Middle East and Africa Opioids Market Forecast (2018-2023)

10.2.5.1. Saudi Arabia Opioids Market Forecast (2018-2023)

10.2.5.2. UAE Opioids Market Forecast (2018-2023)

10.2.5.3. Egypt Opioids Market Forecast (2018-2023)

10.2.5.4. Nigeria Opioids Market Forecast (2018-2023)

10.2.5.5. South Africa Opioids Market Forecast (2018-2023)

10.2.5.6. Rest of MEA Opioids Market Forecast (2018-2023)

10.3.    Opioids Market Forecast by Product (2018-2023)

10.3.1.      Global Opioids Sales Forecast by Product (2018-2023)

10.3.2.      Global Opioids Sales Market Share Forecast by Product (2018-2023)

10.4.    Opioids Market Forecast by Application (2018-2023)

10.4.1.      Global Opioids Sales Forecast by Application (2018-2023)

10.4.2.      Global Opioids Sales Market Share Forecast by Application (2018-2023)


List of Tables

*You can glance through the list of Tables and Figures when you view the sample copy of Opioids Market.


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*